Abstract

Mutations in FUS and TBK1 often cause aggressive early-onset amyotrophic lateral sclerosis (ALS) or a late-onset ALS and/or frontotemporal dementia (FTD) phenotype, respectively. Co-occurrence of mutations in two or more Mendelian ALS/FTD genes has been repeatedly reported. However, little is known how two pathogenic ALS/FTD mutations in the same patient interact to shape the final phenotype. We screened 28 ALS patients with a known FUS mutation by whole-exome sequencing and targeted evaluation for mutations in other known ALS genes followed by genotype–phenotype correlation analysis of FUS/TBK1 double-mutant patients. We report on new and summarize previously published FUS and TBK1 double-mutant ALS/FTD patients and their families. We found that, within a family, mutations in FUS cause ALS while TBK1 single mutations are observed in FTD patients. FUS/TBK1 double mutations manifested as ALS and without a manifest difference regarding age at onset and disease duration when compared to FUS single-mutant individuals. In conclusion, TBK1 and FUS variants do not seem to interact in a simple additive way. Rather, the phenotype of FUS/TBK1 double-mutant patients appears to be dominated by the FUS mutation.

Highlights

  • Amyotrophic lateral sclerosis (ALS) is a devastating motor neuron disease

  • We extend the previous knowledge about FUS/TBK1 double-mutant patients by whole-exome sequencing of additional 28 patients with FUS mutation

  • We report and summarize eight patients with rare variants in both FUS and TBK1, weigh the evidence for their pathogenicity, and study the phenotype of double-mutant compared to single-mutant ALS patients

Read more

Summary

Introduction

Amyotrophic lateral sclerosis (ALS) is a devastating motor neuron disease. Its heritability is estimated to be in the range of 30–60%. Mutations in the RNA-binding protein FUS can cause ALS and FTD in very rare instances. The heterozygous ALS- and FTD-causing mutations in TBK1 usually lead to a loss of function of one TBK1 allele and have been suggested to impair the cellular role of TBK1 in autophagy and glial immune responses [5]. Both genes act most likely at an upstream position in different cellular pathways. We and others have previously described several ALS patients with simultaneous mutations in FUS and TBK1 [11, 12]. We compare the co-segregation of genotypes and phenotypes in two families in which mutations in TBK1 and FUS occur separately or in combination and compare them with previously reported and newly identified TBK1/FUS double-mutant patients

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call